Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naitee Ting

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cardiology and Therapy|October 7, 2016
A Prospective, Randomized, Open-Label Study to Evaluate Two Management Strategies for Gastrointestinal Symptoms in Patients Newly on Treatment with DabigatranDaniel O'Dea, Jacqueline Whetteckey, Naitee Ting
Journal of Biopharmaceutical Statistics|December 8, 2022
How to select the initial dose for a pediatric study?Jingjing Ye, Youwei Bi, Naitee Ting
Therapeutic Innovation & Regulatory Science|May 24, 2021
Proof of Concept: Drug Selection? Or Dose Selection? Thoughts on Multiplicity IssuesQian H Li, Qiqi Deng, Naitee Ting
Journal of Biopharmaceutical Statistics|February 26, 2010
Two confidence interval approaches on the dependability coefficient in a two-factor crossed designNaitee Ting, Joseph C Cappelleri, Andrew G Bushmakin
Statistics in Medicine|June 11, 2025
Consistency-Based Approach to Adjust for Multiplicity in Confirmatory Subgroup AnalysisQiqi Deng, Qian Li, Naitee Ting, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2014
Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studiesRichard ZuWallack, Lisa Allen, Gemzel Hernandez, et al.
Statistics in Medicine|July 12, 2002
Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designsJorge Quiroz, Naitee Ting, Greg C G Wei, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2018
Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial dataDavid M Mannino, Emmanuelle M Clerisme-Beaty, Joanne Franceschina, et al.
Clinical Therapeutics|March 6, 2012
Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trialArya M Sharma, George Bakris, Joel M Neutel, et al.
Contact Dermatitis|October 11, 2008
Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjectsJeanett Borregaard, Lone Skov, Lisy Wang, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cardiology and Therapy|October 7, 2016
A Prospective, Randomized, Open-Label Study to Evaluate Two Management Strategies for Gastrointestinal Symptoms in Patients Newly on Treatment with DabigatranDaniel O'Dea, Jacqueline Whetteckey, Naitee Ting
Journal of Biopharmaceutical Statistics|December 8, 2022
How to select the initial dose for a pediatric study?Jingjing Ye, Youwei Bi, Naitee Ting
Therapeutic Innovation & Regulatory Science|May 24, 2021
Proof of Concept: Drug Selection? Or Dose Selection? Thoughts on Multiplicity IssuesQian H Li, Qiqi Deng, Naitee Ting
Journal of Biopharmaceutical Statistics|February 26, 2010
Two confidence interval approaches on the dependability coefficient in a two-factor crossed designNaitee Ting, Joseph C Cappelleri, Andrew G Bushmakin
Statistics in Medicine|June 11, 2025
Consistency-Based Approach to Adjust for Multiplicity in Confirmatory Subgroup AnalysisQiqi Deng, Qian Li, Naitee Ting, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2014
Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studiesRichard ZuWallack, Lisa Allen, Gemzel Hernandez, et al.
Statistics in Medicine|July 12, 2002
Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designsJorge Quiroz, Naitee Ting, Greg C G Wei, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2018
Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial dataDavid M Mannino, Emmanuelle M Clerisme-Beaty, Joanne Franceschina, et al.
Clinical Therapeutics|March 6, 2012
Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trialArya M Sharma, George Bakris, Joel M Neutel, et al.
Contact Dermatitis|October 11, 2008
Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjectsJeanett Borregaard, Lone Skov, Lisy Wang, et al.
Pageof 3